180 related articles for article (PubMed ID: 23900262)
1. Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans.
Dias SJ; Zhou X; Ivanovic M; Gailey MP; Dhar S; Zhang L; He Z; Penman AD; Vijayakumar S; Levenson AS
Sci Rep; 2013; 3():2331. PubMed ID: 23900262
[TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer.
Liu T; Yang M; Yang S; Ge T; Gu L; Lou G
Hum Pathol; 2013 Oct; 44(10):2275-81. PubMed ID: 23866297
[TBL] [Abstract][Full Text] [Related]
3. Metastasis-associated protein 1 (MTA1) overexpression is closely associated with shorter disease-free interval after complete resection of histologically node-negative esophageal cancer.
Li SH; Wang Z; Liu XY
World J Surg; 2009 Sep; 33(9):1876-81. PubMed ID: 19575142
[TBL] [Abstract][Full Text] [Related]
4. Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma.
Li WF; Liu N; Cui RX; He QM; Chen M; Jiang N; Sun Y; Zeng J; Liu LZ; Ma J
J Transl Med; 2012 Apr; 10():78. PubMed ID: 22537306
[TBL] [Abstract][Full Text] [Related]
5. YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence.
Sheridan CM; Grogan TR; Nguyen HG; Galet C; Rettig MB; Hsieh AC; Ruggero D
Oncotarget; 2015 Apr; 6(10):7470-80. PubMed ID: 25797255
[TBL] [Abstract][Full Text] [Related]
6. Close association of metastasis-associated protein 1 overexpression with increased angiogenesis and poor survival in patients with histologically node-negative gastric cancer.
Deng X; Du L; Wang C; Yang Y; Li J; Liu H; Zhang J; Wang L; Zhang X; Li W; Zhang X; Wang S; Dong Z
World J Surg; 2013 Apr; 37(4):792-8. PubMed ID: 23283219
[TBL] [Abstract][Full Text] [Related]
7. Metastasis-associated protein 1 nuclear expression is closely associated with tumor progression and angiogenesis in patients with esophageal squamous cell cancer.
Li SH; Tian H; Yue WM; Li L; Gao C; Li WJ; Hu WS; Hao B
World J Surg; 2012 Mar; 36(3):623-31. PubMed ID: 22270988
[TBL] [Abstract][Full Text] [Related]
8. MTA1: A Vital Modulator in Prostate Cancer.
Ma J; Li C; Qian H; Zhang Y
Curr Protein Pept Sci; 2022; 23(7):456-464. PubMed ID: 35792131
[TBL] [Abstract][Full Text] [Related]
9. The subcellular distribution and function of MTA1 in cancer differentiation.
Liu J; Xu D; Wang H; Zhang Y; Chang Y; Zhang J; Wang J; Li C; Liu H; Zhao M; Lin C; Zhan Q; Huang C; Qian H
Oncotarget; 2014 Jul; 5(13):5153-64. PubMed ID: 24970816
[TBL] [Abstract][Full Text] [Related]
10. MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers.
Jang KS; Paik SS; Chung H; Oh YH; Kong G
Cancer Sci; 2006 May; 97(5):374-9. PubMed ID: 16630134
[TBL] [Abstract][Full Text] [Related]
11. Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies.
Martin MD; Hilsenbeck SG; Mohsin SK; Hopp TA; Clark GM; Osborne CK; Allred DC; O'Connell P
Breast Cancer Res Treat; 2006 Jan; 95(1):7-12. PubMed ID: 16244788
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis.
Ma K; Fan Y; Hu Y
Medicine (Baltimore); 2018 Oct; 97(41):e12292. PubMed ID: 30313027
[TBL] [Abstract][Full Text] [Related]
13. Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1).
Kai L; Wang J; Ivanovic M; Chung YT; Laskin WB; Schulze-Hoepfner F; Mirochnik Y; Satcher RL; Levenson AS
Prostate; 2011 Feb; 71(3):268-80. PubMed ID: 20717904
[TBL] [Abstract][Full Text] [Related]
14. Expression of MTA1 in endometriosis and its relationship to the recurrence.
Zhang J; Wang H; Meng Q; Chen J; Wang J; Huang S
Medicine (Baltimore); 2018 Aug; 97(35):e12115. PubMed ID: 30170442
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Li SH; Tian H; Yue WM; Li L; Li WJ; Chen ZT; Hu WS; Zhu YC; Qi L
Ann Surg Oncol; 2011 Jul; 18(7):2048-56. PubMed ID: 21290196
[TBL] [Abstract][Full Text] [Related]
16. Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate Cancer.
Carleton NM; Zhu G; Miller MC; Davis C; Kulkarni P; Veltri RW
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1237. PubMed ID: 32587951
[TBL] [Abstract][Full Text] [Related]
17. Relationships between metastasis-associated protein (MTA) 1 and lymphatic metastasis in tonsil cancer.
Park JO; Jung CK; Sun DI; Joo YH; Kim MS
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1329-34. PubMed ID: 21240515
[TBL] [Abstract][Full Text] [Related]
18. Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Li YT; Wu HL; Kao JH; Cheng HR; Ho MC; Wang CC; Chen PJ; Chen DS; Liu CJ
Hepatology; 2019 Jul; 70(1):184-197. PubMed ID: 30802976
[TBL] [Abstract][Full Text] [Related]
19. MTA1 Is Up-regulated in Colorectal Cancer and Is Inversely Correlated with Lymphatic Metastasis.
Li J; Ye L; Sun PH; Satherley L; Hargest R; Zhang Z; Jiang WG
Cancer Genomics Proteomics; 2015; 12(6):339-45. PubMed ID: 26543080
[TBL] [Abstract][Full Text] [Related]
20. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
